4.__Pharmaceutical services.__The department shall enter into agreements with pharmacists for the provision of the following services to further the purposes of this chapter:

A.__Drug use review;

B.__Management of drug therapy;

C.__Case management of consumers identified as at high risk of medication-related problems; and

D.__Management of consumer compliance.

5.__Rebates.__The department shall negotiate with pharmaceutical manufacturers for the payment of rebates by the manufacturers.__Manufacturers are ineligible for participation in the program if they have not reached rebate agreements with the department.

6.__Evaluation.__The department shall undertake an annual evaluation of the program and the department's participation in the consortium, which may be contracted out to a nonprofit organization.__The annual evaluation must include any drug formulary adopted by the department, drug efficacy, prescription size, consumer satisfaction and consumer demand for prescription drugs not covered by the program.__The annual evaluation must be distributed to the Prescription Drug Advisory Committee as established in section 263, and to the public by January 1, 2000 and each year thereafter.

7.__Rulemaking.__The department shall adopt rules to implement this chapter.__Rules adopted under this chapter are major substantive rules as defined by Title 5, chapter 375, subchapter II-A.

§262.__Prescription Drug Dedicated Fund

The Prescription Drug Dedicated Fund, referred to in this chapter as the "fund," is established to fund the program.__ Rebates received from prescription drug manufacturers pursuant to this chapter must be deposited in the fund.__Participating pharmacies and hospitals shall deposit in the fund payments for prescription drugs received from consumers, minus the service fee that may be retained by the pharmacies and hospitals pursuant to rule adopted by the department.__The fund may also receive any payments due from 3rd-party payors in payment for prescription